Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
In MS Diagnosis, the Case for Κ-FLC Index
An international expert panel has recommended that the intrathecal kappa free light chain (κ‑FLC) index be added to the next revision of multiple sclerosis (MS) diagnostic criteria as a quantitative, cost‑effective alternative to oligoclonal bands (OCBs). κ‑FLC can be measured rapidly by nephelometry or turbidimetry, offering higher sensitivity than the IgG index (60‑70%) while avoiding the labor‑intensive, rater‑dependent nature of OCB testing. The 2025 McDonald criteria already acknowledge κ‑FLC as interchangeable with OCBs, and emerging data suggest the κ‑FLC index also predicts future inflammatory activity and disability progression. The panel’s consensus underscores κ‑FLC’s diagnostic and prognostic utility, positioning it as a robust biomarker for MS.
Chronic Pain Management: Balancing Relief and Regulation
Chronic pain affects roughly 24.3% of U.S. adults, about 60 million people, with 8.5% experiencing high‑impact pain that limits daily function. Modern care emphasizes a multimodal toolbox—targeted exercise, cognitive‑behavioral therapy, judicious medication, and interventional procedures—to restore function and reduce opioid reliance....
Get a Fuller Picture with Fitbit's Personal Health Coach
Fitbit unveiled the next phase of its AI‑driven personal health coach, boosting sleep‑stage accuracy by 15% and introducing a more granular Sleep Score that tracks latency and interruptions. The company highlighted new research published in *Nature* that predicts insulin resistance...
How Google Is Using AI to Improve Health for Everyone
Google announced a suite of AI‑driven health initiatives, beginning with a partnership in Arkansas to pilot a rural‑health transformation model. The company is allocating $10 million through Google.org to reimagine clinician education alongside leading medical societies. AI enhancements are also rolling...
NQO1‐Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell‐Targeted Migrastatic (Small 16/2026)
Researchers introduced BQTML‑CB, an NQO1‑responsive prodrug that releases cytochalasin B inside tumor cells, disrupting actin filaments and halting migration and proliferation. The design exploits the enzyme NQO1, overexpressed in many aggressive cancers, to achieve tumor‑selective activation while sparing NQO1‑deficient cells and...
Suckerin Colloids and Hydrogels With Low Immunogenicity as Resorbable and Hemostatic Tissue Adhesives for Wound Healing
Researchers have engineered recombinant suckerin‑12 colloids and hydrogels that act as wet‑resistant tissue adhesives. The materials exhibit stronger adhesion than traditional mussel‑derived proteins and outperform fibrin glue in hemostasis, cell proliferation, and wound closure in animal models. Low cytotoxicity, minimal...
AI in Healthcare Forum
The AI in Healthcare Forum convened clinicians, executives, and technologists in Boston to showcase real‑world AI applications across care delivery, operations, and governance. Sessions covered policy frameworks, data challenges, scaling strategies, and emerging clinical AI tools, featuring leaders from Sutter...
Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting
The FDA issued a third complete response letter rejecting Aldeyra Therapeutics' lead dry‑eye candidate, reproxalap, citing a lack of substantial evidence and inconsistent efficacy data. The agency noted the drug failed to demonstrate clear benefit in well‑controlled studies, though no...
AI Augments, Not Replaces, Doctors in Future Healthcare
Much of the conversation around healthcare and AI right now pits doctors and AI against each other. This is the wrong framing. Yes, it is important to have studies that look at how good AI is at various tasks that physicians...
Physician Burnout Stems From Lost Authority and Opacity
This week on Lifers, Graham Walker is “sounding the alarm” for physicians. * 50% of medical students already plan to quit before they finish school. * Doctors are becoming "factory employees," losing their authority to care for patients. * Tech focuses on the...
CT-Like Chest Imaging at the Bedside Sans Radiation?
Engineers at the University of Hong Kong have unveiled SonoMeta, an AI‑assisted ultrasound lens built from metamaterials that can image heart and lung structures up to 10 cm behind the rib cage with CT‑like resolution. Validation shows spatial resolution under 500 µm...
Doctor Calls for Meningitis B Catch-Up Jabs for All UK Teens Born Before 2015
Dr Niamh Lynch is urging the NHS to launch a catch‑up MenB vaccination programme for all UK teenagers born before September 2015, after a deadly meningitis B outbreak in Kent claimed two lives and left eleven seriously ill. The strain now...
AI in the Hands of Clinicians: A Look at the Digital Stethoscope
AI‑augmented digital stethoscopes such as the Eko CORE 500 are bringing machine‑learning diagnostics to the bedside. The device records heart sounds, a three‑lead ECG and runs cloud‑based algorithms that flag atrial fibrillation, murmurs and reduced left‑ventricular ejection fraction, with studies reporting...
Kenya’s Flood Response Shows the Promise — and Limits — of ‘One Health’
In 2024, severe flooding in Kenya’s Tana River County sparked a cholera outbreak that overwhelmed local health facilities. Authorities deployed a One Health strategy, integrating human, animal, and environmental agencies to coordinate surveillance, water treatment, and vaccination campaigns. The approach...
Can Bristol Myers Squibb’s Pipeline Strategy Offset a Major Patent Cliff?
Bristol Myers Squibb faces a major patent cliff as flagship drugs like Revlimid, Pomalyst, Opdivo and Eliquis lose exclusivity, threatening its revenue base. To counteract the decline, the company is reshaping its pipeline through internal R&D and high‑profile acquisitions, emphasizing...
Why Veins Don’t All Behave the Same
Phlebotomists often encounter unexpected bruising despite proper technique, a problem rooted in vein elasticity. The tunica media’s smooth muscle responds to autonomic signals, causing vasoconstriction under stress and vasodilation with heat, which directly alters vein size and firmness. Aging, tight...
Moving Beyond Individual-Level Factors: Evidence-Based Strategies to Advance Structural Competency in Sports and Exercise Medicine
The editorial calls for sports and exercise medicine to shift focus from individual behavior to structural determinants of musculoskeletal health. It highlights persistent racial and ethnic disparities in physical activity and rehabilitation outcomes, rooted in housing policies, economic inequities, and...
Effectiveness of Cryotherapy on Pain Intensity, Range of Motion, Swelling and Function in the Postoperative Care of Musculoskeletal Disorders: A...
A systematic review and meta‑analysis of 28 randomized trials involving roughly 3,000 postoperative patients evaluated cryotherapy’s impact on pain, range of motion, swelling, and function after musculoskeletal surgery. The analysis showed statistically significant pain reductions (MD −0.77 to −0.41) and modest improvements...
The “Third Way” For Digital Health Engagement
Kris Narayan argues that today’s health‑tech landscape is split between EMR giants that protect clinical data within the office and consumer‑focused AI tools that demand medical expertise to use. Both approaches fail to engage patients during the daily "micro‑moments" after...
Apply Proven Futures Methods to Shape
Analyzing the future of medicine and healthcare, especially during the rise of digital health and artificial intelligence, should rely on established futures methods that the discipline of futures studies has been using for decades. By employing such methods, healthcare professionals,...
So, What Can You Use Your HSA/FSA Money For?
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) let employees spend pre‑tax dollars on qualified medical costs, and many retailers now classify beauty and wellness items as eligible. HSA balances typically roll over year‑over‑year, while most FSAs expire unless...
MPs Call for Urgent Overhaul of Vascular Care to Prevent Avoidable Amputations
A cross‑party All‑Party Parliamentary Group released a report urging sweeping reforms to England’s vascular care. It warns that delayed diagnosis and fragmented referral pathways lead to thousands of preventable lower‑limb amputations each year. The paper recommends establishing multidisciplinary Foot Protection...
Are Pig Organs the Future of Transplantation?
The United States faces a transplant shortage of over 100,000 patients, prompting research into xenotransplantation using genetically engineered pig organs. Recent cases—David Bennett’s pig heart in 2022, Lawrence Faucette’s in 2023, and Tim Andrews’ pig kidney in 2025—demonstrate feasibility, with...
Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts
Eli Lilly shares fell after HSBC issued a lone sell rating, the second bearish call in a year, citing overinflated expectations for its weight‑loss drugs. Analysts led by Rajesh Kumar downgraded the stock to a sell‑equivalent rating and lowered the...
NVIDIA and Persistent Systems Partner to Bring ‘Agentic AI’ to Drug Discovery
Persistent Systems has partnered with NVIDIA to bring Agentic AI to the healthcare and life‑sciences sector, focusing on computational drug discovery. Leveraging NVIDIA’s full AI stack—including AI Enterprise, BioNeMo, the NeMo Agent Toolkit, and NIM microservices—Persistent built GenMolVS, a generative...
CMS Implements Enhanced Oversight for MAC MBI Lookup Tools
The Centers for Medicare & Medicaid Services (CMS) is tightening oversight of Medicare Administrative Contractor (MAC) MBI lookup tools to combat hospice fraud. The agency will now match MBI searches against submitted claims using National Provider Identifiers (NPIs) and may...
The 2026 Convergence: Big Tech, Agentic AI and the Restructuring of the Global HealthTech Ecosystem
In early 2026 the world’s leading technology firms launched agentic health AI platforms, shifting from passive information retrieval to proactive health stewardship. Microsoft introduced Copilot Health, aggregating data from over 50,000 U.S. hospitals and dozens of wearable ecosystems, while Amazon...
Azara Healthcare Joins MEDITECH Alliance to Integrate Population Health Platform
Azara Healthcare has entered the MEDITECH Alliance, linking its Azara DRVS population‑health platform with the MEDITECH Expanse electronic health record. The integration is aimed at community and critical‑access hospitals, offering an out‑of‑the‑box data aggregation layer that combines clinical records, claims...
EMA Marketing Authorization of New Drugs in February 2026
In February 2026 the European Commission and the CHMP granted marketing authorisations and positive opinions for a slate of innovative therapies spanning COVID‑19, oncology, cardiology, immunology and rare diseases. Notable approvals include Moderna’s mNEXSPIKE COVID‑19 vaccine, Hansoh’s Aumseqa for EGFR‑mutated...
Center for Radiology Education to Provide Medical Imaging Scholarships at John Patrick University
The Center for Radiology Education (CRE) announced a nationwide scholarship initiative for students enrolling in medical imaging programs at John Patrick University (JPU). Up to 5,000 scholarships worth as much as $10,000 each will be awarded in 2026, targeting a...
Despite Pressures, Healthcare Construction Spending to Increase
Construction spending for hospitals and clinics is set to hit $30.7 billion in 2026, an 11.6% jump from 2025 and the highest level since the 2024 record. ConstructConnect projects a 7% compounded annual growth rate, reaching $38.8 billion by 2030, driven by...
For Newer Sepsis Diagnostics, What the Studies Show
Newer sepsis diagnostics such as monocyte distribution width (MDW), Intellisep, and MeMed BV are showing promise in early clinical studies but each has distinct limitations. MDW, available on the Beckman Coulter CBC platform, improves sepsis detection when combined with white‑blood‑cell...
AI Agents in Health Care: What They Say when We Aren’t Listening
Moltbook, a Reddit‑style platform for autonomous AI agents, has become a live laboratory where "moltbots" discuss health, medicine, and human well‑being without human moderation. By February 2026, over 1,000 posts referenced human health, revealing three dominant themes: AI envisioning its...
Transcarent Partners with Bluespine to Launch Payment Integrity Category for Self-Insured Employers
Transcarent has added a new “Payment Integrity” category to its Experience Store through a partnership with AI‑driven health‑tech firm Bluespine. The service targets the $300 billion annual loss from fraud, waste and abuse in U.S. healthcare by analyzing every medical and...
Turner Goes Vertical on $900M Pennsylvania Hospital Expansion
Turner Construction has begun vertical construction on an 11‑story, 600,000‑square‑foot expansion at Geisinger Wyoming Valley Medical Center, a $900 million project that will raise bed capacity from 356 to 500 and increase operating rooms to 18. The tower will contain more...
DDW Highlights: 17 March 2026
In this DDW Highlights episode, Bruno Quinney reviews four major stories: a Mayo Clinic study linking the Parkinson's protein alpha‑synuclein to dramatically faster Alzheimer’s progression in women; a Texas A&M‑funded project testing extracellular vesicle (EV) therapy to modulate microglia and...
Tricuspid Stenosis: An Echocardiographic Guide
Tricuspid stenosis (TS) is an exceptionally rare right‑sided valve obstruction that often goes unnoticed on routine transthoracic echocardiography. Although its hemodynamics mirror mitral stenosis—producing a diastolic pressure gradient and leaflet doming—its low prevalence makes accurate detection challenging. Echocardiography now supersedes...
One Decision-Maker per Team: Inside Pfizer’s Cross-Functional Operating Model
Pfizer accelerated its COVID‑19 vaccine development by overhauling its traditional operating model. The company compressed four‑level approval chains and shifted decision authority from committees to a single leader per cross‑functional team. This one‑decision‑maker approach enabled rapid iteration and alignment across...
Pfizer Reports P-II (FOURLIGHT-1) Trial Data on Atirmociclib Combination for 2L Metastatic Breast Cancer
Pfizer disclosed topline Phase II (FOURLIGHT‑1) data showing that atirmociclib combined with fulvestrant outperformed fulvestrant alone or everolimus + exemestane in 264 HR+, HER2‑negative metastatic breast cancer patients previously treated with CDK 4/6 inhibitors. The trial met its primary endpoint, delivering a statistically significant...
Mechanical Forces: Emerging Tools for Diagnosis and Therapy
Mechanical forces play essential roles in biology. Measuring and controlling these forces represent emerging strategies for disease diagnosis and therapeutic intervention, to complement more traditional approaches. This review article, published today in Nature Reviews Bioengineering (https://t.co/byKGFuVFLH), summarizes the status of...
Single-Cell Analysis Advances Neurodegenerative Disease Understanding
Neurodegenerative diseases at the single-cell level, a powerful tool to differentiate and better understand https://t.co/Pkz4qW0ELM @jclinicalinvest https://t.co/LiJ4FojRYZ
Cancer Vaccines Could Transform Treatment and Prevention – but Misinformation About mRNA Vaccines Threatens Their Potential
Scientists are accelerating development of mRNA cancer vaccines, with more than 120 clinical trials targeting melanoma, brain, breast, lung and prostate tumors. Early studies, such as personalized vaccines for glioblastoma, demonstrate rapid immune activation and improved survival. Simultaneously, a false...
CytomX CRC Data Demand Double‑Take, Not Clear Verdict
Some clinical updates tell you exactly what they are. Others ask to be read twice. CytomX’s latest CRC data belong firmly in the second category. Is the die cast? https://t.co/dfdPxx4zXs https://t.co/y9QAoahMut
Trump Pushes Drug Pricing Overhaul Despite Congressional Resistance
The Trump administration is "gearing up for war" to push Congress to codify its drug pricing policy — despite little appetite for it on the Hill. Still, the pharma industry sees risk in the back-and-forth. https://t.co/DR2LotvXFq
Magic Mushroom-Infused Products Appear in Colorado Gas Stations – What Public Health Officials Want Consumers to Know
Colorado health officials have seized and destroyed PolkaDot‑branded chocolate bars, gummies and shots sold in gas stations that were marketed as mushroom blends but contained psilocybin, psilocin and synthetic tryptamines. The products bypassed FDA oversight by exploiting the dietary supplement...
Paralysis Patients Type Using Brain‑computer Interface
A brain-computer interface allowed people with paralysis to type with their minds https://t.co/W5icU6ye8c via @statnews
Roche Launches Biggest Hybrid‑cloud AI Factory with Nvidia
At 3,500+ Blackwell chips, Roche is building the "largest announced hybrid-cloud AI factory" in biopharma with Nvidia: https://t.co/99Eih7EnRD
Health Insurance Priority for Government, to Cover All by 2033: Nirmala Sitharaman
Finance Minister Nirmala Sitharaman announced that India aims for universal health‑insurance coverage by 2033, building on a market that insured 58 crore lives in FY 2024‑25. The sector’s premium volume hit Rs 1,17,505 crore, with public, private and standalone insurers contributing roughly equally. Recent regulatory...
China’s Control Over US Drug Supply Alarms Lawmakers
U.S. lawmakers warned that China dominates the supply chain for essential hospital and outpatient medicines, especially generic drugs that fill 90% of prescriptions. Witnesses at a Senate Aging Committee hearing highlighted that China controls roughly 90% of key starting materials...
Scientists Finally Reveal How This Alzheimer’s Drug Really Works
Scientists from VIB and KU Leuven have identified the mechanism by which lecanemab (Leqembi) clears amyloid plaques in Alzheimer’s disease. Their study shows that the antibody’s Fc fragment engages microglia, reprogramming them to phagocytose and degrade plaques. Removing the Fc...